A detailed history of Alhambra Investment Partners LLC transactions in Amgen Inc stock. As of the latest transaction made, Alhambra Investment Partners LLC holds 3,513 shares of AMGN stock, worth $1.17 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
3,513
Previous 3,218 9.17%
Holding current value
$1.17 Million
Previous $914,000 20.02%
% of portfolio
0.61%
Previous 0.51%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$262.75 - $319.31 $77,511 - $94,196
295 Added 9.17%
3,513 $1.1 Million
Q1 2024

Apr 15, 2024

SELL
$268.87 - $324.56 $9,410 - $11,359
-35 Reduced 1.08%
3,218 $914,000
Q1 2023

Apr 18, 2023

SELL
$225.79 - $275.2 $11,741 - $14,310
-52 Reduced 1.57%
3,253 $786,000
Q4 2022

Jan 19, 2023

SELL
$229.03 - $291.01 $12,138 - $15,423
-53 Reduced 1.58%
3,305 $0
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 0.03%
3,358 $757,000
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $12,458 - $13,863
54 Added 1.63%
3,357 $817,000
Q1 2022

Apr 19, 2022

SELL
$219.27 - $242.57 $8,551 - $9,460
-39 Reduced 1.17%
3,303 $799,000
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $38,781 - $44,382
-195 Reduced 5.51%
3,342 $752,000
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $11,679 - $12,957
50 Added 1.43%
3,537 $862,000
Q1 2021

Apr 16, 2021

BUY
$221.91 - $258.6 $266,292 - $310,320
1,200 Added 52.47%
3,487 $868,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $9,953 - $11,852
-46 Reduced 1.97%
2,287 $526,000
Q3 2020

Nov 17, 2020

BUY
$234.65 - $260.95 $7,978 - $8,872
34 Added 1.48%
2,333 $593,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $35,012 - $42,964
177 Added 8.34%
2,299 $542,000
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $63,784 - $84,595
-350 Reduced 14.16%
2,122 $430,000
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $467,727 - $601,190
2,472 New
2,472 $596,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $179B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alhambra Investment Partners LLC Portfolio

Follow Alhambra Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alhambra Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alhambra Investment Partners LLC with notifications on news.